Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand).

Novartis Media Relations E-mail: [email protected] Novartis Investor Relations Central investor relations line: +41 ...